Cancer Therapeutics

Method for Repurposing FDA-approved Therapeutics & Composition for Treating Mesothelioma

Metabolically-fit Immunotherapies Portfolio

QSOX1 as an anti-neoplastic drug target

Carbohydrate-Targeted Antitumor Agents

Compounds to Modulate Retinoid X Receptors

Modified Aminoglycoside based polymers

Replication System, Novel Polymerases, and Uses for Threose Nucleic Acid

Novel Human C3 Derivatives for Therapeutic Complement Depletion

Compositions for Treatment of HER2 Positive Cancers

Compounds to Modulate Retinoid X Receptors